Expression of pro-angiogenic cytokines and their inhibition by dexamethasone in an ex vivo model of nasal polyps

Biochemical and Biophysical Research Communications

Volumn 379, Issue 2, 2009, Pages 255-260

  Park, Seong Kook ^a   Jang, Won Hee ^a   Yang, Young Il ^a  

^a Inje University   (South Korea)

Author keywords

Angiogenesis; Ex vivo model; Nasal polyps; Organ culture

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; DEXAMETHASONE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INTERLEUKIN 6; INTERLEUKIN 8; MELANOMA GROWTH STIMULATORY ACTIVITY FACTOR; MONOCYTE CHEMOTACTIC PROTEIN 1; VASCULOTROPIN;

ARTICLE; CYTOKINE PRODUCTION; DISEASE MODEL; DOWN REGULATION; DRUG EFFECT; HUMAN; HUMAN TISSUE; NOSE POLYP; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE CULTURE;

CYTOKINES; DEXAMETHASONE; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MODELS, BIOLOGICAL; NASAL POLYPS; NEOVASCULARIZATION, PATHOLOGIC; ORGAN CULTURE TECHNIQUES; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 58149512050     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.12.034     Document Type: Article

References (21)

1. Berg O.H., Lie K., and Steinsvag S.K. The effect of decongestive nose drops on human respiratory mucosa in vitro. Laryngoscope 104 (1994) 1153-1158
2. Resau J.H., Cottrell J.R., Elligett K.A., and Hudson E.A. Cell injury and regeneration of human epithelium in organ culture. Cell Biol. Toxicol. 3 (1987) 441-458
3. Kleinsasser N.H., Juchhoff J., Wallner B.C., Bergner A., Harreus U.A., Gamarra F., Buhrlen M., Huber R.M., and Rettenmeier A.W. The use of mini-organ cultures of human upper aerodigestive tract epithelia in ecogenotoxicology. Mutat. Res. 561 (2004) 63-73
4. Chambard M., Verrier B., Gabrion J., and Mauchamp J. Polarity reversal of inside-out thyroid follicles cultured within collagen gel: reexpression of specific function. Biol. Cell 51 (1984) 315-326
5. Hellquist H.B. Nasal polyps update, Histopathology. Allergy Asthma Proc. 17 (1996) 237-242
6. Early S.B., Hise K., Han J.K., Borish L., and Steinke J.W. Hypoxia stimulates inflammatory and fibrotic responses from nasal-polyp derived fibroblasts. Laryngoscope 117 (2007) 511-515
7. Dvorak H.F., Brown L.F., Detmar M., and Dvorak A.M. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am. J. Pathol. 146 (1995) 1029-1039
8. Jackson J.R., Seed M.P., Kircher C.H., Willoughby D.A., and Winkler J.D. The codependence of angiogenesis and chronic inflammation. FASEB J. 11 (1997) 457-465
9. Benson M. Pathophysiological effects of glucocorticoids on nasal polyp: an update. Curr. Opin. Allergy Clin. Immunol. 5 (2005) 31-35
10. Folkman J., and Klagsbrun M. Angiogenic factors. Science 235 (1987) 442-447
11. Connolly D.T., Heuvelman D.M., Nelson R., Olander J.V., Eppley B.L., and Delfino J.J. Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J. Clin. Invest. 84 (1989) 1470-1478
12. Coste A., Brugel L., Maitre B., Boussat S., Papon J.F., Wingerstmann L., Peynegre R., and Escudier E. Inflammatory cells as well as epithelial cells in nasal polyps express vascular endothelial growth factor. Eur. Respir. J. 15 (2000) 367-372
13. Gosepath J., Brieger J., Lehr H.A., and Mann W.J. Expression, localization and significance of vascular permeability/vascular endothelial growth factor in nasal polyps. Am. J. Rhinol. 19 (2005) 7-13
14. Bateman N.D., Shahi A., Feeley K.M., and Woolford T.J. Vascular endothelial growth factor in nasal polyps: a comparison of asthmatic and non-asthmatic patients. Clin. Otolaryngol. 29 (2004) 677-681
15. Park S.K., Lee W.J., and Yang Y.I. Organ culture at the air-liquid interface maintains structural and functional integrities of inflammatory and fibrovascular cells of nasal polyps. Am. J. Rhinol. 21 (2007) 402-407
16. Pedersen C.B., Mygind N., Sorensen H., and Prytz S. Long-term treatment of nasal polyps with beclomethasone dipropionate aerosol. II. Clinical results. Acta Otolaryngol. (Stockh) 82 (1976) 256-259
17. Koedam J.A., Smink J.J., and van Buul-Offers S.C. Glucocorticoids inhibit vascular endothelial growth factor expression in growth plate chondrocyte. Mol. Cell. Endocrinol. 197 (2002) 35-44
18. Luo J.C., Shin V.Y., Liu E.S.L., Ye Y.N., Wu W.k.K., So W.H.L., chang F.Y., and Cho C.H. Dexamethasone delays ulcer healing by inhibition of angiogenesis in rat stomachs. Eur. J. Pharmacol. 485 (2004) 275-281
19. Matsune S., Sun D., Ohori J., Nishimoto K., Fukuiwa T., Ushikai M., and Kurono Y. Inhibition of vascular endothelial growth factor by macrolides in cultured fibroblasts from nasal polyp. Laryngoscope 115 (2005) 1953-1956
20. Iwai A., Fujii Y., Kawakami S., Takazawa R., Kageyama Y., Yoshida M.A., and Kihara K. Down-regulation of vascular endothelial growth factor in renal cell carcinoma cells by glucocorticoids. Mol. Cell. Endocrinol. 226 (2004) 11-17
21. Zhanq Q., Tanq X., Lu Q., Zhanq Z., Rao J., and Le A.D. Green tea extract and (-)-epigallocatechin-3-gallate inhibit hypoxia- and serum-induced HIF-1alpha protein accumulation and VEGF expression in human cervical carcinoma and hepatoma cells. Mol. Cancer Ther. 5 (2006) 1227-1238